SK187399A3 - Adition salt of maleate acid and of 5-(2-ethyl-2(h)-tetrazol-5- yl)-1-methyl-1,2,3,6-tetrahydropyridine, preparation method thereof, pharmaceutical composition containing the same and use thereof - Google Patents

Adition salt of maleate acid and of 5-(2-ethyl-2(h)-tetrazol-5- yl)-1-methyl-1,2,3,6-tetrahydropyridine, preparation method thereof, pharmaceutical composition containing the same and use thereof Download PDF

Info

Publication number
SK187399A3
SK187399A3 SK1873-99A SK187399A SK187399A3 SK 187399 A3 SK187399 A3 SK 187399A3 SK 187399 A SK187399 A SK 187399A SK 187399 A3 SK187399 A3 SK 187399A3
Authority
SK
Slovakia
Prior art keywords
addition salt
tetrahydropyridine
ethyl
methyl
tetrazol
Prior art date
Application number
SK1873-99A
Other languages
English (en)
Slovak (sk)
Inventor
Bech Michael Sommer
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SK187399A3 publication Critical patent/SK187399A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1873-99A 1997-07-01 1998-07-01 Adition salt of maleate acid and of 5-(2-ethyl-2(h)-tetrazol-5- yl)-1-methyl-1,2,3,6-tetrahydropyridine, preparation method thereof, pharmaceutical composition containing the same and use thereof SK187399A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
SK187399A3 true SK187399A3 (en) 2000-06-12

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1873-99A SK187399A3 (en) 1997-07-01 1998-07-01 Adition salt of maleate acid and of 5-(2-ethyl-2(h)-tetrazol-5- yl)-1-methyl-1,2,3,6-tetrahydropyridine, preparation method thereof, pharmaceutical composition containing the same and use thereof

Country Status (25)

Country Link
EP (1) EP0994869A1 (ru)
JP (1) JP2002507215A (ru)
KR (1) KR20010014297A (ru)
CN (1) CN1261361A (ru)
AR (1) AR013096A1 (ru)
AU (1) AU735751B2 (ru)
BG (1) BG103933A (ru)
BR (1) BR9810331A (ru)
CA (1) CA2293324A1 (ru)
CO (1) CO4940483A1 (ru)
EA (1) EA200000081A1 (ru)
HU (1) HUP0002876A2 (ru)
IL (1) IL133093A0 (ru)
IS (1) IS5278A (ru)
JO (1) JO2031B1 (ru)
MA (1) MA25138A1 (ru)
NO (1) NO996580D0 (ru)
PE (1) PE116099A1 (ru)
PL (1) PL337184A1 (ru)
SK (1) SK187399A3 (ru)
TN (1) TNSN98120A1 (ru)
TR (1) TR199903283T2 (ru)
UY (2) UY25069A1 (ru)
WO (1) WO1999001448A1 (ru)
ZA (1) ZA985498B (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
WO1997017074A1 (en) * 1995-11-06 1997-05-15 H. Lundbeck A/S Treatment of traumatic brain injury

Also Published As

Publication number Publication date
BR9810331A (pt) 2000-09-05
EP0994869A1 (en) 2000-04-26
CN1261361A (zh) 2000-07-26
UY25177A1 (es) 2000-12-29
MA25138A1 (fr) 2001-04-02
HUP0002876A2 (hu) 2001-06-28
IS5278A (is) 1999-11-30
AU735751B2 (en) 2001-07-12
EA200000081A1 (ru) 2000-08-28
PL337184A1 (en) 2000-08-14
KR20010014297A (ko) 2001-02-26
AU8102098A (en) 1999-01-25
PE116099A1 (es) 1999-11-23
IL133093A0 (en) 2001-03-19
NO996580L (no) 1999-12-30
TNSN98120A1 (fr) 2005-03-15
CA2293324A1 (en) 1999-01-14
ZA985498B (en) 1999-01-20
CO4940483A1 (es) 2000-07-24
AR013096A1 (es) 2000-12-13
WO1999001448A1 (en) 1999-01-14
JP2002507215A (ja) 2002-03-05
UY25069A1 (es) 1998-12-21
JO2031B1 (en) 1999-05-15
NO996580D0 (no) 1999-12-30
TR199903283T2 (xx) 2000-06-21
BG103933A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
AU720358B2 (en) Tropane-derivatives, their preparation and use
US6436928B1 (en) Selective neurokinin antagonists
DE60132309T2 (de) Amin-derivate zur behandlung von apoptosis
SK279453B6 (sk) Estery tienylkarboxylových kyselín a aminoalkoholo
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
WO2003074525A1 (fr) Compose heterocyclique azote
EP0555478A1 (en) Pyrimidine derivative and medicine
DE69732090T2 (de) Indol-2,3-dione-3-oxim derivate
EP3331889B1 (en) Cyclic compounds useful as modulators of tnf alpha
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
SK285159B6 (sk) Hemisulfátová soľ (1S,4R)-cis-4-[2-amino-6-(cyklopropylamino)-9H- purin-9-yl]-2-cyklopentén-1-metanolu, spôsob jej výroby, farmaceutický prostriedok s jej obsahom a jej použitie
EP0880524B1 (de) Adenosin-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA3037766C (en) Dextrorphan-derivatives with suppressed central nervous activity
SK187399A3 (en) Adition salt of maleate acid and of 5-(2-ethyl-2(h)-tetrazol-5- yl)-1-methyl-1,2,3,6-tetrahydropyridine, preparation method thereof, pharmaceutical composition containing the same and use thereof
SK15032000A3 (sk) Maleínan paroxetínu, spôsob jeho výroby a jeho použitie
DE60222015T2 (de) Ccr-3-rezeptorantagonisten vii
SK152095A3 (en) Crystalline (+) l-hydrogentartrate, preparation method thereof, pharmaceutical composition containing its and its use
JPH0242080A (ja) ヘテロ四環ラクタム誘導体
CA1336514C (en) Cyclo-octane neuroprotective agents
MXPA99011450A (en) 5-(2-ethyl-2h
CZ477899A3 (cs) 5-(2-ethyI-2H-tetrazol-5-yl)-l-methyl-l,2,3,6- tetrahydropyridinmaleátová adiční sůl
AU662730B2 (en) Neuroprotectant agents
JP2719063B2 (ja) 置換3−アミノキヌクリジンp物質拮抗剤
DE60216807T2 (de) Triazepin-derivate als neurotrope mittel
EP0024582A1 (de) Benzodiazepinone, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel